CNE000001L31
CNE000001L31
SL PHARM
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 623.643.929 | 660.419.604 | 5.6% |
| Cost of Revenue | 236.087.807 | 211.533.255 | 11.6% |
| Gross Profit | 387.556.122 | 448.886.349 | 13.7% |
| 390.206.084 | 405.116.990 | 3.7% | |
| Operating Income | -2.649.963 | 43.769.359 | 106.1% |
| Pretax Income | -278.144.237 | -133.749.653 | 108.0% |
| Net Income Common Stockholders | -347.197.803 | -74.065.658 | 368.8% |
| -- | -- | -- | |
| -- | -- | -- |